Literature DB >> 17547685

Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men.

Masayuki Torigoe1, Hideo Matsui, Yasuhiro Ogawa, Hisashi Murakami, Ryuichiro Murakami, Xian Wu Cheng, Yasushi Numaguchi, Toyoaki Murohara, Kenji Okumura.   

Abstract

OBJECTIVE: Adiponectin is an adipocyte-derived, antiatherogenic protein that is present in plasma as a large multimeric structure of high molecular weight (HMW) and in a trimer or hexamer form (non-HMW). The biological activities of these isoforms have not yet been elucidated. We therefore examined the effect of these isoforms on endothelial function in healthy young men.
DESIGN: One hundred apparently healthy young men without overt cardiovascular disease (mean age 30 years) were recruited in this cross-sectional study based on voluntary enrollment. MEASUREMENTS: We evaluated endothelial function estimated by flow-mediated dilatation (FMD) of the brachial artery during reactive hyperaemia, and measured total and HMW adiponectin levels.
RESULTS: Both HMW and non-HMW adiponectin levels showed a significant, inverse correlation with body mass index (BMI). FMD was significantly correlated with fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), malondialdehyde-modified low density lipoprotein (MDA-LDL), LDL particle size, and HMW adiponectin (r = 0.320, P = 0.001), but not non-HMW adiponectin (r = 0.125, P = 0.22). In multivariate analysis, HMW adiponectin and MDA-LDL were selected as independent factors capable of influencing FMD. No variables determined nitroglycerin-induced dilatation.
CONCLUSIONS: These results suggest that even in young men, plasma adiponectin levels can predict endothelial dysfunction before any overt vascular disease has occurred. HMW adiponectin may be more useful as a marker of endothelial dysfunction than total adiponectin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547685     DOI: 10.1111/j.1365-2265.2007.02876.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  22 in total

1.  Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.

Authors:  Zhongjie Fu; Chatarina A Lofqvist; Zhuo Shao; Ye Sun; Jean-Sebastien Joyal; Christian G Hurst; Ricky Z Cui; Lucy P Evans; Katherine Tian; John Paul SanGiovanni; Jing Chen; David Ley; Ingrid Hansen Pupp; Ann Hellstrom; Lois E H Smith
Journal:  Am J Clin Nutr       Date:  2015-02-04       Impact factor: 7.045

Review 2.  Review: adiponectin in retinopathy.

Authors:  Zhongjie Fu; Yan Gong; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Biochim Biophys Acta       Date:  2016-05-04

Review 3.  Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements.

Authors:  Luc Bruyndonckx; Vicky Y Hoymans; Katrien Lemmens; José Ramet; Christiaan J Vrints
Journal:  Pediatr Res       Date:  2016-02-11       Impact factor: 3.756

Review 4.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Interaction between Adiponectin and Aldosterone.

Authors:  Colleen Flynn; George L Bakris
Journal:  Cardiorenal Med       Date:  2011-04-15       Impact factor: 2.041

6.  Visceral and subcutaneous adiposity and brachial artery vasodilator function.

Authors:  Nisha I Parikh; Michelle J Keyes; Martin G Larson; Karla M Pou; Naomi M Hamburg; Joseph A Vita; Christopher J O'Donnell; Ramachandran S Vasan; Gary F Mitchell; Udo Hoffmann; Caroline S Fox; Emelia J Benjamin
Journal:  Obesity (Silver Spring)       Date:  2009-03-12       Impact factor: 5.002

7.  Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function.

Authors:  Jessica L Fargnoli; Qi Sun; Deanna Olenczuk; Lu Qi; Ying Zhu; Frank B Hu; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2009-11-17       Impact factor: 6.664

8.  A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer.

Authors:  Yukari Ohbuchi; Yasunobu Suzuki; Ikuo Hatakeyama; Yoshifumi Nakao; Atsuya Fujito; Tsuyoshi Iwasaka; Keiichi Isaka
Journal:  Int J Clin Oncol       Date:  2013-08-22       Impact factor: 3.402

Review 9.  The role of obesity in the pathogenesis of hypertension.

Authors:  Yolanda E Bogaert; Stuart Linas
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-23

Review 10.  Adiponectin and insulin cross talk: the microvascular connection.

Authors:  Lina Zhao; Zhuo Fu; Zhenqi Liu
Journal:  Trends Cardiovasc Med       Date:  2014-08-07       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.